Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- Study type
- Other
- Study name
- GLOBOCAN 2022
- Design
- Population-based statistical report (GLOBOCAN estimates of the International Agency for Research on Cancer, IARC)
- Sample size
- Global estimates for 36 cancer types in 185 countries
- Source
- CA A Cancer J Clinicians · 2024
In plain words
This report shows that in 2022 nearly 20 million people worldwide were diagnosed with cancer and 9.7 million people died of it. Lung cancer was the most common cancer, followed by breast cancer in women. The number of new cases is expected to reach 35 million by 2050, but prevention, such as avoiding tobacco, preventing overweight and obesity, and controlling infections, could prevent many of these cases.
Key results
Study population
Populations of 20 world regions in 185 countries; estimates are given for 36 cancer types and by sex.
Endpoints
Cancer incidence and mortality in 2022 by cancer type, sex and world region, with a discussion of trends, underlying factors and the outlook for cancer prevention and control.
Safety and side effects
Given the nature of the study (a statistical report) and the abstract, there is no safety/adverse event section.
Clinical significance and place in guidelines
This paper is a statistical report and does not recommend any specific treatment. Based on the abstract, its results highlight the importance of investing in prevention (tobacco, overweight and obesity, infection) and in health resource planning. The four- to five-fold difference in incidence rates between world regions reflects differences in risk factors and in access to services. The status of recommendations in clinical guidelines should be checked separately.
Limitations
These figures are estimates, not direct counts; the projection of 35 million cases by 2050 is based on demographic change alone. Details of data quality in each country are not given in the abstract and are available in the full text of the paper.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.